What factors should be considered when prescribing anticoagulants for patients with scleroderma-associated vasculopathy, and how does therapy influence vascular complications and overall disease progression?
Gaurav ChauhanContributor
What are the considerations for anticoagulant therapy in patients with scleroderma-associated vasculopathy?
Share